![Thomas Bures](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Bures
Comptroller/Controller/Auditor bei
BRUKER CORPORATION
Vermögen: 192 456 $ am 30.06.2026
Profil
Thomas Bures is Chief Accounting Officer at Bruker Corp.
since 2025.
Formerly, Mr. Bures was Senior VP, Chief Financial & Accounting Officer at Pieris Pharmaceuticals, Inc. from 2021 to 2024, Vice President & Controller at Genocea Biosciences, Inc. from 2015 to 2017, Vice President & Assistant Controller at PAREXEL International Corp., and Chief Financial Officer at Palvella Therapeutics, Inc. Education includes an undergraduate degree from College of the Holy Cross (Massachusetts).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.02.2026 | 3.198 ( 0 % ) | 192 456 $ | 30.06.2026 |
Aktive Positionen von Thomas Bures
| Unternehmen | Position | Beginn |
|---|---|---|
| BRUKER CORPORATION | Comptroller/Controller/Auditor | 13.01.2025 |
Ehemalige bekannte Positionen von Thomas Bures
| Unternehmen | Position | Ende |
|---|---|---|
| PIERIS PHARMACEUTICALS | Finanzdirektor/CFO | 13.12.2024 |
| GENOCEA BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 01.12.2017 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Thomas Bures
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
31
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Bruker Corp.
 Bruker Corp. Medical SpecialtiesHealth Technology Manufactures analytical and medical instruments | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
